Meeting
2016 ASCO Annual Meeting
A randomized phase II trial of systemic chemotherapy with or without trastuzumab followed by surgery in HER2 positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger study).
Authors
Masanori Tokunaga
Division of Gastric Surgery, Shizuoka Cancer Center, Nagaizumi, Japan
Masanori Tokunaga , Nozomu Machida , Junki Mizusawa , Hiroshi Katayama , Hiroya Taniguchi , Kohei Shitara , Toshihiko Tomita , Takaki Yoshikawa , Narikazu Boku , Takeshi Sano , Mitsuru Sasako , Masanori Terashima
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Clinical Trial Registration Number
UMIN000016920
Citation
J Clin Oncol 34, 2016 (suppl; abstr TPS4143)
DOI
10.1200/JCO.2016.34.15_suppl.TPS4143
Abstract #
TPS4143
Poster Bd #
129a
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
A randomized phase II trial of preoperative chemotherapy of S-1/CDDP with or without trastuzumab followed by surgery in HER2 positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger Study).
First Author: Masanori Tokunaga
Poster
2018 Gastrointestinal Cancers Symposium
A phase II trial of first-line FOLFIRINOX for patients with advanced gastroesophageal adenocarcinoma.
First Author: Haeseong Park
Poster
2017 ASCO Annual Meeting
Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2 positive resectable esophagogastric adenocarcinoma: Petrarca—A phase II trial of the German AIO.
First Author: Ralf Hofheinz
Poster
2017 Gastrointestinal Cancers Symposium
Survival results of a multicenter phase II study of trastuzumab with S-1 alone in elderly patients with HER-2 positive advanced gastric cancer (JACCRO GC-06).
First Author: Kazuhiro Nishikawa